drugset / Trial / NCT00774969

Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease

NCT00774969

Phase 1 Completed 19 enrolled S.L.A. Pharma AG
NaSingle-groupBasic science

Summary

The purpose of this study is to evaluate the blood levels of Metronidazole after application to the peri anal area after a single dose and 6 or 7 days application.

Timeline

Start
2007-10
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 10 % Other